Enzyme Research Frontiers

Explore cutting-edge studies on enzyme kinetics, structure, and industrial applications

Research Articles

A Cellular Double Agent: How a New Drug Outsmarts Resistant Breast Cancer

Discover how MHY218, a new HDAC inhibitor, fights tamoxifen-resistant breast cancer by triggering dual cell death pathways through epigenetic reprogramming.

Owen Rogers
Oct 22, 2025

Popular Articles